öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Àî·¼

±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27

µ¼Ê¦ÐÕÃû£ºÀî·¼
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º31

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£º»ù´¡Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º 1¡¢ÈËÇ÷»¯Òò×ÓCXCL8µÄ¶¨µãÍ»±ä¡¢¸ßÇ׺ÍÁ¦µÄÊÜÌåÞ׿¹¼Á£¨CXCR1/2ÊÜÌåÞ׿¹¼Á£©µÄ¹¹½¨... [Õ¹¿ª]


Ñо¿ÁìÓò£º 1¡¢ÈËÇ÷»¯Òò×ÓCXCL8µÄ¶¨µãÍ»±ä¡¢¸ßÇ׺ÍÁ¦µÄÊÜÌåÞ׿¹¼Á£¨CXCR1/2ÊÜÌåÞ׿¹¼Á£©µÄ¹¹½¨¡¢±í´ï¼°ÌåÄÚÍâ»îÐÔµÄÑо¿£¨¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£©¡£2¡¢CXCR1/2ÊÜÌåÞ׿¹¼Á¶ÔÑ×Ö¢ºÍ×ÔÉíÃâÒßÐÔ¼²²¡£¨Ï¸¾úÐÔ·ÎÑס¢ÒøÐ¼²¡¡¢¹Ø½ÚÑ×£©µÄÖÎÁÆ×÷Óü°Æä»úÖÆµÄÑо¿£¨¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£©¡£3¡¢ÈËCXCR1/2ÊÜÌåÞ׿¹¼ÁµÄ¶ÔÖ×ÁöÉú³¤¡¢×ªÒƺÍѪ¹ÜÐγɵÄÒÖÖÆ×÷Óü°Æä»úÖÆµÄÑо¿£¨Ç°ÁÐÏÙ°©¡¢¸Î°©ºÍºÚÉ«ËØÁö£©¡£ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£º lifang16@hotmail.com


¸öÈ˼òÊö :
Àî·¼ ,²©Ê¿£¬½ÌÊÚ£¬²©Ê¿Éú¡¢Ë¶Ê¿Éúµ¼Ê¦¡£ÏÖÈδóÁ¬Ò½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÃâÒßѧ½ÌÑÐÊÒÖ÷ÈΡ£ÈÙ»ñ´óÁ¬Ò½¿Æ´óѧÏȽø¹¤×÷Õß¡¢½ÌѧÃûʦ¡¢Á¼Ê¦ÒæÓѵÈ¡£

¿ÆÑй¤×÷ :
³Ðµ£µÄ¹ú¼Ò¼¶ÏîÄ¿£º£¨½ü5Ä꣩
¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¸ßÇ׺ÍÁ¦CXC1/2ÊÜÌåÞ׿¹¼Á¿¹Ñ××÷ÓõÄÑо¿08Äê1ÔÂ-10Äê12ÔÂ
ÁÉÄþÊ¡½ÌÓýÌüÈ˸ßÇ׺ÍÁ¦CXCR1/2È«ÐÂÞ׿¹¼ÁµÄ¹¹½¨¼°Æä¿¹Ñ×Ö¢Ñо¿2008Äê1ÔÂ-2010Äê12ÔÂ
´ú±íÐÔÂÛÎÄ£¨½ü5Ä꣩£º
1. Xin Lliu, Jing Peng, Wenchang Sun, Shufen Yang, Guoying Deng, Fang Li, Jya-wei Chen and John R. Gordon. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice. Tohoku J Exp. Med 2012, 228, 147~156 ͨѶ×÷Õß
2.YuanHua Qin£¬FuShun Fan£¬Ying Zhao£¬Ying Cui£¬XiaoQing Wei£¬Kazuhiro Kohama£¬John R. Gordon£¬Fang Li£¬Ying Gao. Recombinant Human CXCL8(3-72)K11R/G31P Regulates Smooth Muscle Cell Proliferation and Migration Through Blockage of Interleukin-8 Receptor. 2013 Research Communication 65£¨1£© 67~75ͨѶ×÷Õß
3. Jing Wei, Jing Peng, Bing Wang, Hong Qu, ShiyiWang, Aziz Faisal,Jia-Wei Cheng, John R. Gordon, and Fang Li. CXCR1/CXCR2 Antagonism Is Effective in Pulmonary Defense against Klebsiella pneumoniae Infection. 2013.BioMed Research International Volume, 1-6ͨѶ×÷Õß
4. Jing Wei,, Xiangyu Chen, Qiang Li, Jifei Chen, Noman Khan, Bing Wang, Jya-Wei Cheng, John R. Gordon and Fang. Li. ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression , andameliorate cisplatin-induced nephrotoxicity 2014 Oncology reports 31: 1599-1604ͨѶ×÷Õß
5. Lingyun Li, Muhammad Noman Khan, Qiang Li, Xiangyu Chen, Jing Wei,Bing Wang, Jya -wei Cheng, John R. Gordon and Fang Li .G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high?dose cisplatin-induced nephrotoxicity 2015 Oncology reports 33: 751-757. ͨѶ×÷Õß

½ÌÓý±³¾° :
1999-2001£º²©Ê¿ºó£¬¼ÓÄôó ÈøË¹¿¨³¹Î´óѧ΢ÉúÎïϵ ÃâÒßѧ£»1995-1999£º ²©Ê¿ºó£¬±±¾©´óѧҽѧ²¿ÈËÀ༲²¡»ùÒòÑо¿ÖÐÐÄ £¨Ô­±±¾©Ò½¿Æ´óѧÃâÒßϵ·Ö×ÓÃâÒßʵÑéÊÒ£© ҽѧÃâÒßѧ£»1992-1995£º²©Ê¿ ÖйúÔ¤·Àҽѧ¿ÆÑ§Ôº Á÷Ðв¡Ñ§Î¢ÉúÎïѧÑо¿Ëù ΢ÉúÎïѧÓëÃâÒßѧ£»1986-1990£ºÒ½Ñ§Ë¶Ê¿ ´óÁ¬Ò½¿Æ´óѧ ΢ÉúÎïѧÓëÃâÒßѧ£»1977-1982£ºÒ½Ñ§Ñ§Ê¿ ÁÉÄþҽѧԺ£¨Ô­½õÖÝҽѧԺ£©ÁÙ´²Ò½Ñ§¡£


Ïà¹Ø»°Ìâ/ÃâÒßѧ ´óÁ¬Ò½¿Æ´óѧ ΢ÉúÎïѧ ҽѧ µ¼Ê¦

  • ÁìÏÞʱ´ó¶îÓÅ»Ýȯ,Ïí±¾Õ¾Õý°æöλÔÓéÀֵǼÈë¿ÚÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ!
    ´ó¶îÓÅ»Ýȯ
    ÓÅ»ÝȯÁìÈ¡ºó72СʱÄÚÓÐЧ£¬10ÍòÖÖ×îÐÂöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿¼Ö¤Ààµç×Ó´òÓ¡öλÔÓéÀÖ¹Ù·½appÏÂÔØÈÎÄãÑ¡¡£º­¸ÇÈ«¹ú500ÓàËùԺУöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿Î¡¢200¶àÖÖÖ°Òµ×ʸñöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¡¢1100¶àÖÖ¾­µä½Ì²Ä£¬²úÆ·ÀàÐͰüº¬µç×ÓÊé¡¢Ìâ¿â¡¢È«Ì×öλÔÓéÀÖ¹Ù·½appÏÂÔØÒÔ¼°ÊÓÆµ£¬ÎÞÂÛÄúÊÇöλÔÓéÀÖ¹Ù·½appÏÂÔØ¸´Ï°¡¢¿¼Ö¤Ë¢Ì⣬»¹ÊÇ¿¼Ç°³å´ÌµÈ£¬²»Í¬ÀàÐ͵IJúÆ·¿ÉÂú×ãÄúѧϰÉϵIJ»Í¬ÐèÇó¡£ ...
    öλÔÓéÀֵǼÈë¿ÚÏÂÔØÓÅ»Ýȯ ±¾Õ¾Ð¡±à FreeÒ¼°Û·ÖÑ§Ï°Íø 2022-09-19
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÓÚÇÚ
    µ¼Ê¦ÐÕÃû£ºÓÚÇÚÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚ¸ßѪѹÓëÐÄË¥Ïà¹Ø»ù´¡ÓëÁÙ´²Ñо¿Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚ¸ßѪѹÓëÐÄË¥Ïà¹Ø»ù´¡ÓëÁÙ´²Ñо¿[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º**µç×ÓÓʼþ£ºyuqin060621@126.com¸öÈ˼òÊö:ÓÚÇÚ£¬19 ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÅ־ΰ
    µ¼Ê¦ÐÕÃû£ºÕÅ־ΰÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÉó¤Ç°ÁÐÏÙ¼²²¡ÕïÖΣ¬ÓÈÆäרעǰÁÐÏÙØà³ýÊõ£¨¼¤¹âºÍµÈÀë×Ó£©£¬¸¹Ç»¾µÇ°ÁÐÏÙ°©¸ùÖÎÊõµÈ·½ÃæÑо¿£»...[Õ¹¿ª]Ñо¿ÁìÓò£ºÉó¤Ç°ÁÐÏÙ¼²²¡ÕïÖΣ¬ÓÈÆäרעǰÁÐÏÙØà³ýÊõ£¨¼¤¹âºÍµÈÀë×Ó£©£¬¸¹Ç»¾µÇ°ÁÐ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÍõÈôÓê
    µ¼Ê¦ÐÕÃû£ºÍõÈôÓêÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º³¤ÆÚÖÂÁ¦ÓÚÖ×ÁöµÄ·Å»¯ÁƵֿ¹Óë×ªÒÆ¸´·¢»úÖÆµÄÑо¿Ñо¿ÁìÓò£º³¤ÆÚÖÂÁ¦ÓÚÖ×ÁöµÄ·Å»¯ÁƵֿ¹Óë×ªÒÆ¸´·¢»úÖÆµÄÑо¿[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºwangruoyu1963@163.com¸öÈ˼òÊö:ÍõÈôÓ꣬½Ì ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ËÕÔÆ
    µ¼Ê¦ÐÕÃû£ºËÕÔÆÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºÖ÷ÈÎҽʦµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚ¹ÇÕÛÓúºÏÒÔ¼°¼¡ëìËðÉ˵ÄÏà¹ØÑо¿Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚ¹ÇÕÛÓúºÏÒÔ¼°¼¡ëìËðÉ˵ÄÏà¹ØÑо¿[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºsuyunll@sina.com¸öÈ˼òÊö:ËÕÔÆ£¬Ò½Ñ§²©Ê¿£¬Ö÷ÈÎҽʦ£¬ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Íõ±¾½Ü
    µ¼Ê¦ÐÕÃû£ºÍõ±¾½ÜÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºÖ÷ÈÎҽʦµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖÂÁ¦ÓڹɹÇÍ·»µËÀµÄ»ù´¡ºÍÁÙ´²Ñо¿Ñо¿ÁìÓò£ºÖÂÁ¦ÓڹɹÇÍ·»µËÀµÄ»ù´¡ºÍÁÙ´²Ñо¿[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºwbjflyer@aliyun.com¸öÈ˼òÊö:Íõ±¾½Ü£¬²©Ê¿£¬Ö÷ÈÎҽʦ£¬Ë¶Ê¿Ñо¿Éú ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-лÁ«ÄÈ
    µ¼Ê¦ÐÕÃû£ºÐ»Á«ÄÈÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÍ¨Ñ¶·½Ê½:µç×ÓÓʼþ£ºxieln1963@163.com¸öÈ˼òÊö:лÁ«ÄÈ£¬Å®£¬54Ë꣨³öÉúÄêÔÂ1963.7£©£¬Ò½Ñ§²©Ê¿£¬Ö÷ÈÎҽʦ£¬½ÌÊÚ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦£¬´óÁ¬´óѧ¸½ÊôÖÐɽҽԺѭ»·ËÄ¿ÆÖ÷ÈΡ£ÁÉÄþʡϸ°ûÉú ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-³Â·Å
    µ¼Ê¦ÐÕÃû£º³Â·ÅÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÊÓÍøÄ¤¼²²¡µÄÁÙ´²Óë»ù´¡Ñо¿Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÊÓÍøÄ¤¼²²¡µÄÁÙ´²Óë»ù´¡Ñо¿[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºcfyzsbyy@163.com¸öÈ˼òÊö:³Â·Å£¬Å®£¬1972Äê9Ô³öÉú£¬Ò½Ñ§²©Ê¿ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-³ÂÓ¦Öù
    µ¼Ê¦ÐÕÃû£º³ÂÓ¦ÖùÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÄÔËðÉË£¨È±ÑªÐÔÄÔѪ¹Ü²¡¡¢ÄÔ³öѪ¡¢ÅÁ½ðÉ­²¡¡¢ÍÑËèÇʼ²²¡£©µ¼ÖµÄÉñ¾­Ñª¹Üµ¥Ôª±ä»¯¼°Æä...[Õ¹¿ª]Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚÄÔËðÉË£¨È±ÑªÐÔÄÔѪ¹Ü²¡¡¢ÄÔ³öѪ¡¢ÅÁ½ðÉ­²¡¡¢ÍÑËèÇʼ²²¡£©µ¼Ö嵀 ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¸ðÑÇÀö
    µ¼Ê¦ÐÕÃû£º¸ðÑÇÀöÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚΧÊõÆÚ»úÌå·Î¡¢ÄÔµÈÖØÒªÔàÆ÷ËðÉ˼°±£»¤Ïà¹ØÑо¿Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚΧÊõÆÚ»úÌå·Î¡¢ÄÔµÈÖØÒªÔàÆ÷ËðÉ˼°±£»¤Ïà¹ØÑо¿[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºhappygezi81@163.com¸öÈ˼òÊö ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÁõÑî
    µ¼Ê¦ÐÕÃû£ºÁõÑîÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚŧ¶¾Ö¢Ïà¹ØÑª¹ÜÉøÂ©£¬Å§¶¾Ö¢Ïà¹Ø¼±ÐÔ·ÎËðÉË£¬ARDSµÄ·¢²¡»úÖÆµÄÑо¿Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚŧ¶¾Ö¢Ïà¹ØÑª¹ÜÉøÂ©£¬Å§¶¾Ö¢Ïà¹Ø¼±ÐÔ·ÎËðÉË£¬ARDSµÄ·¢²¡»úÖÆµÄÑо¿[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºli ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÂíÉÙÁÖ
    µ¼Ê¦ÐÕÃû£ºÂíÉÙÁÖÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÅ§¶¾Ö¢¼°¶àÆ÷¹Ù¹¦ÄÜÕϰ­×ÛºÏÕ÷µÄ·¢²¡»úÀíÓëÖÎÁÆÑо¿ÁìÓò£ºÅ§¶¾Ö¢¼°¶àÆ÷¹Ù¹¦ÄÜÕϰ­×ÛºÏÕ÷µÄ·¢²¡»úÀíÓëÖÎÁÆ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºm_slin@sina.com¸öÈ˼òÊö:ÂíÉÙÁÖ£¬Ë¶Ê¿£¬Ö÷ÈÎҽʦ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ì¶½­Èª
    µ¼Ê¦ÐÕÃû£ºì¶½­ÈªÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£º¸±Ö÷ÈÎҽʦµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º³¤ÆÚÖÂÁ¦ÓÚ¶àÆ÷¹Ù¹¦Äܲ»È«·¢²¡»úÖÆµÄÁÙ´²¼°»ù´¡Ñо¿£¬Ìرð¶ÔÖØÖ¢ÂýÐÔ×èÈûÐԷμ²²¡¼±ÐÔ·¢×÷»¼ÕßÓÐ...[Õ¹¿ª]Ñо¿ÁìÓò£º³¤ÆÚÖÂÁ¦ÓÚ¶àÆ÷¹Ù¹¦Äܲ»È«·¢²¡»úÖÆµÄÁÙ´²¼°»ù´¡Ñо¿£¬Ìرð¶ÔÖØÖ¢ÂýÐÔ×èÈû ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ôßÄÏ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ËÎÔª×Ú
    µ¼Ê¦ÐÕÃû£ºËÎÔª×ÚÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º31ËùÊôԺУ£ºôßÄÏ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ò½Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÒŲú´úл²¡µÄ·Ö×ÓÕï¶ÏºÍ²úǰÕï¶Ï¡£Ñо¿ÁìÓò£ºÒŲú´úл²¡µÄ·Ö×ÓÕï¶ÏºÍ²úǰÕï¶Ï¡£[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º**¸öÈ˼òÊö:ÈÙÓþÓë½±Àø£º1.AsianYoungInvestiga ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ºþÄÏ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÔåµ
    µ¼Ê¦ÐÕÃû£ºÕÔåµÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£ººþÄÏ´óѧËùÊôԺϵ£ºÔÀ´ÊéÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÑо¿ÖصãΪÃ÷ÇåÒÔÀ´µÄÁ÷ÐÐÎÄ»¯Óë¾­¼ÃÕþÖεĽ»Á÷Ê·Ñо¿ÁìÓò£ºÑо¿ÖصãΪÃ÷ÇåÒÔÀ´µÄÁ÷ÐÐÎÄ»¯Óë¾­¼ÃÕþÖεĽ»Á÷Ê·[ÊÕÆð]¸öÈ˼òÊö:ÕÔåµ£¬ÃÀ¹ú¶íÀÕ¸Ô´óѧUniversityofOregonÖйúÊ·²©Ê¿£¨ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ºþÄÏ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Îļѱ¦
    µ¼Ê¦ÐÕÃû£ºÎļѱ¦ÐÔ±ð£ºÈËÆøÖ¸Êý£º31ËùÊôԺУ£ººþÄÏ´óѧËùÊôԺϵ£ºÐÅÏ¢¿ÆÑ§Ó빤³ÌѧԺְ³Æ£ºÖúÀí½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
öλÔÓéÀÖ(xinhui)¹Ù·½ÍøÕ¾_öλÔÓéÀÖappÏÂÔØÈë¿Ú